Literature DB >> 7924787

Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness.

M J Jackson1, L A Bindoff, K Weber, J N Wilson, P Ince, K G Alberti, D M Turnbull.   

Abstract

OBJECTIVE: To determine if diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DIDMOAD) combined with a cerebellar syndrome is associated with a systemic disorder of respiratory chain function as found in similar genetic syndromes. CASE: A muscle biopsy was taken from a patient with DIDMOAD, and a mitochondrial fraction was prepared. Respiratory chain function was assessed by analysis of intermediary metabolites, histochemical analysis of muscle biopsy, measurement of the activity of individual respiratory chain complexes, oxidative flux through the respiratory chain, and cytochrome concentration and compared with a population with normal respiratory chain function. Mitochondrial DNA from skeletal muscle, brain, and pancreas was examined for major rearrangements and specific point mutations. Brain tissue was examined neuropathologically for abnormalities, particularly those previously described in association with DIDMOAD.
RESULTS: No abnormality was found in mitochondrial oxidation, individual complex activity, or cytochrome concentration. Histochemical analysis and electron microscopy showed no abnormality known to be associated with mitochondrial dysfunction. A single-base substitution at position 12308 of the mitochondrial genome was found, but no major rearrangement of mitochondrial DNA was demonstrated. Neuropathological examination revealed severe demyelination and gliosis in the optic nerves and loss of Purkinje cells associated with gliosis in the white matter in the cerebellum.
CONCLUSIONS: We have found no evidence that DIDMOAD is associated with a systemic abnormality of respiratory chain function. The mitochondrial DNA single-base substitution noted is likely to be a polymorphism rather than a pathogenic point mutation. We have confirmed that DIDMOAD may be associated with a neurodegenerative disorder, but the cause of this remains undetermined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924787     DOI: 10.2337/diacare.17.7.728

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

1.  Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1.

Authors:  C Hardy; F Khanim; R Torres; M Scott-Brown; A Seller; J Poulton; D Collier; J Kirk; M Polymeropoulos; F Latif; T Barrett
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Intracellular mitochondrial triplasmy in a patient with two heteroplasmic base changes.

Authors:  S K Bidooki; M A Johnson; Z Chrzanowska-Lightowlers; L A Bindoff; R N Lightowlers
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

3.  A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle.

Authors:  K Weber; J N Wilson; L Taylor; E Brierley; M A Johnson; D M Turnbull; L A Bindoff
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

4.  DIDMOAD syndrome; further studies and muscle biochemistry.

Authors:  T G Barrett; K Poulton; S Bundey
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Molecular characterization of WFS1 in patients with Wolfram syndrome.

Authors:  Johannes M W van ven Ouweland; Kim Cryns; Ronald J E Pennings; Inge Walraven; George M C Janssen; J Antonie Maassen; Bernard F E Veldhuijzen; Alexander B Arntzenius; Dick Lindhout; Cor W R J Cremers; Guy Van Camp; Lambert D Dikkeschei
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

6.  Wolfram syndrome: a clinicopathologic correlation.

Authors:  Justin B Hilson; Saumil N Merchant; Joe C Adams; Jeffrey T Joseph
Journal:  Acta Neuropathol       Date:  2009-05-16       Impact factor: 17.088

7.  Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain.

Authors:  A A Morris; R W Taylor; M A Birch-Machin; M J Jackson; M G Coulthard; L A Bindoff; R J Welch; N Howell; D M Turnbull
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

8.  The novel compound heterozygous mutations, V434del and W666X, in WFS1 gene causing the Wolfram syndrome in a Chinese family.

Authors:  Jie Hong; Yu-Wen Zhang; Hui-Jie Zhang; Hui-Ying Jia; Yu Zhang; Xiao-Yi Ding; Dan-Yang Zhou; Hui-Ping Chen; Xiao-Hua Jiang; Bin Cui; Xiao-Ying Li; Guang Ning
Journal:  Endocrine       Date:  2009-01-22       Impact factor: 3.633

9.  Wolfram Syndrome presenting with optic atrophy and diabetes mellitus: two case reports.

Authors:  Masoud Reza Manaviat; Maryam Rashidi; Seyed Mohammad Mohammadi
Journal:  Cases J       Date:  2009-12-19

10.  Early brain vulnerability in Wolfram syndrome.

Authors:  Tamara Hershey; Heather M Lugar; Joshua S Shimony; Jerrel Rutlin; Jonathan M Koller; Dana C Perantie; Alex R Paciorkowski; Sarah A Eisenstein; M Alan Permutt
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.